Pharmaceutical Preparations · DE · CIK 1699382
PMV Pharmaceuticals develops precision oncology therapies targeting p53 mutations to eliminate cancer cells
Comparable business profile · signals at a glance
In the 90 days to Oct 23, 2025: 1 sold $1.5M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 23, 2025 | Orbimed Capital Gp V LlcTenPercentOwner | Sell | 1,000,000 | $1.52 | $1.5M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.